Vertex Pharmaceuticals Inc

مادة اعلانية

Latest Update: 25 Apr 2025 22:17 Abu Dhabi Time.

Market Status: Opened

VRTX

Vertex Pharmaceuticals Inc

491.42

USD

-1.050

-0.21%

Open

492.54

Prev Close

492.47

PX_VOLUME

MARKET CAP (M)

DAY RANGE

484.50 - 494.43

52 WEEKS

377.85 - 519.88

Stock Statistics

Yearly Change

22.88%

Listed Shares (Million)

257.08

Earnings Multiple

Average 30-day trading volume

1,330,387.86

Price-to-book ratio

7.71

Earnings Per Share

-2.08

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		2,912.00	2,771.90	2,645.60	2,690.60	2,517.70	2,483.50
Gross Profit		2,488.60	2,379.30	2,273.70	2,348.00	2,149.70	2,164.80
Operating Income		1,112.30	1,131.60	934.90	1,216.20	956.00	1,091.00
Profit Margin		31.35	37.71	-135.83	40.87	38.48	41.69

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		11,020.10	9,869.20	8,930.70	7,574.40	6,205.68
Gross Profit		9,489.60	8,607.00	7,850.40	6,670.20	5,469.38
Operating Income		4,395.00	4,307.50	4,378.40	2,779.00	2,869.39
Profit Margin		-4.86	36.68	37.20	30.92	43.70

Balance Sheet

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		22,533.20	22,240.20	20,132.10	23,917.40	22,730.20	21,726.20
Total Liabilities		6,123.60	6,609.30	5,357.40	5,370.80	5,149.80	5,213.40
Total Equity		16,409.60	15,630.90	14,774.70	18,546.60	17,580.40	16,512.80

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		22,533.20	22,730.20	18,150.90	13,432.50	11,751.81
Total Liabilities		6,123.60	5,149.80	4,238.20	3,332.50	3,064.99
Total Equity		16,409.60	17,580.40	13,912.70	10,100.00	8,686.82

Cash Flows Statements - Coming Soon

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

VRTX

Vertex Pharmaceuticals Inc